EPISODE · Feb 2, 2026 · 1 MIN
Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight
from TheBrief.Health · host TheBrief.Health
CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.
Embed this episode
NOW PLAYING
Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight
0:00
1:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of TheBrief.Health?
This episode is 1 minute long.
When was this TheBrief.Health episode published?
This episode was published on February 2, 2026.
Can I download this TheBrief.Health episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!